Trials / Completed
CompletedNCT00909636
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet
A Double-Blind, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of escalating multiple doses of the ABT-333 tablet formulation in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-333 | See arm description for more information |
| DRUG | Placebo | See arm description for more information |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-07-01
- First posted
- 2009-05-28
- Last updated
- 2010-10-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00909636. Inclusion in this directory is not an endorsement.